Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-036309
Filing Date
2025-03-10
Accepted
2025-03-10 16:15:30
Documents
111
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K lctx-20241231.htm   iXBRL 10-K 3534518
2 EX-4.02 lctx-ex4_02.htm EX-4.02 19601
3 EX-4.03(C) lctx-ex4_03c.htm EX-4.03(C) 147575
4 EX-19.01 lctx-ex19_01.htm EX-19.01 137393
5 EX-21.1 lctx-ex21_1.htm EX-21.1 5383
6 EX-23.1 lctx-ex23_1.htm EX-23.1 6246
7 EX-23.2 lctx-ex23_2.htm EX-23.2 6247
8 EX-31.1 lctx-ex31_1.htm EX-31.1 16190
9 EX-31.2 lctx-ex31_2.htm EX-31.2 14489
10 EX-32.1 lctx-ex32_1.htm EX-32.1 13083
11 GRAPHIC img8075409_0.jpg GRAPHIC 209341
12 GRAPHIC img8075409_1.jpg GRAPHIC 110809
13 GRAPHIC img8075409_2.jpg GRAPHIC 52484
14 GRAPHIC img8075409_3.jpg GRAPHIC 50298
15 GRAPHIC img8075409_4.jpg GRAPHIC 32807
16 GRAPHIC img8075409_5.jpg GRAPHIC 16729
17 GRAPHIC img8075409_6.jpg GRAPHIC 332709
18 GRAPHIC img42831238_0.jpg GRAPHIC 16235
  Complete submission text file 0000950170-25-036309.txt   16858888

Data Files

Seq Description Document Type Size
19 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lctx-20241231.xsd EX-101.SCH 1987005
114 EXTRACTED XBRL INSTANCE DOCUMENT lctx-20241231_htm.xml XML 2582278
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

EIN.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12830 | Film No.: 25723877
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)